Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.

Sørensen M, Mikkelsen KS, Frisch K, Bass L, Bibby BM, Keiding S.

J Nucl Med. 2011 Oct;52(10):1566-72. doi: 10.2967/jnumed.111.092924. Epub 2011 Aug 29.

2.

The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.

Mikkelsen KS, Sørensen M, Frisch K, Villadsen GE, Bibby BM, Keiding S.

J Nucl Med. 2014 Apr;55(4):590-4. doi: 10.2967/jnumed.113.125559. Epub 2014 Mar 3.

3.

Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.

Sørensen M, Mikkelsen KS, Frisch K, Villadsen GE, Keiding S.

J Hepatol. 2013 Jun;58(6):1119-24. doi: 10.1016/j.jhep.2013.01.012. Epub 2013 Jan 20.

4.

Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.

Sørensen M, Munk OL, Mortensen FV, Olsen AK, Bender D, Bass L, Keiding S.

Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G27-G36. doi: 10.1152/ajpgi.00004.2008. Epub 2008 May 15.

6.

Accumulation of 2-deoxy-2-[18F]fluoro-D-galactose in the liver by phosphate and uridylate trapping.

Ishiwata K, Ido T, Imahori Y, Yamaguchi K, Fukuda H, Tada M, Matsuzawa T.

Int J Rad Appl Instrum B. 1988;15(3):271-6.

PMID:
3260229
7.

Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.

Trägårdh M, Møller N, Sørensen M.

J Nucl Med. 2015 Sep;56(9):1366-71. doi: 10.2967/jnumed.115.154211. Epub 2015 Jul 9.

8.

2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.

Bak-Fredslund KP, Munk OL, Keiding S, Sørensen M.

Nucl Med Biol. 2016 Sep;43(9):577-80. doi: 10.1016/j.nucmedbio.2016.06.002. Epub 2016 Jun 28.

PMID:
27434609
9.

Hepatic blood perfusion measured by 3-minute dynamic 18F-FDG PET in pigs.

Winterdahl M, Munk OL, Sørensen M, Mortensen FV, Keiding S.

J Nucl Med. 2011 Jul;52(7):1119-24. doi: 10.2967/jnumed.111.088278. Epub 2011 Jun 16.

10.

The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.

Sørensen M, Frisch K, Bender D, Keiding S.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1723-31. doi: 10.1007/s00259-011-1831-z. Epub 2011 May 7.

11.

In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism.

Ishiwata K, Tomura M, Ido T, Iwata R, Itoh J, Kameyama M.

Int J Rad Appl Instrum B. 1989;16(8):775-81.

PMID:
2621112
12.

2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.

Ishiwata K, Yamaguchi K, Kameyama M, Fukuda H, Tada M, Matsuzawa T, Muraishi K, Itoh J, Kawashima K, Takahashi T, et al.

Int J Rad Appl Instrum B. 1989;16(3):247-54.

PMID:
2785512
13.

Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model.

Frisch K, Bender D, Hansen SB, Keiding S, Sørensen M.

Nucl Med Biol. 2011 May;38(4):477-83. doi: 10.1016/j.nucmedbio.2010.11.006. Epub 2011 Feb 4.

14.

2-Deoxy-2-[18F]fluoro-D-galactose: a new tracer for the measurement of galactose metabolism in the liver by positron emission tomography.

Fukuda H, Matsuzawa T, Tada M, Takahashi T, Ishiwata K, Yamada K, Abe Y, Yoshioka S, Sato T, Ido T.

Eur J Nucl Med. 1986;11(11):444-8.

PMID:
3486765
15.

Metabolic liver function measured in vivo by dynamic (18)F-FDGal PET/CT without arterial blood sampling.

Horsager J, Munk OL, Sørensen M.

EJNMMI Res. 2015 May 14;5:32. doi: 10.1186/s13550-015-0110-6. eCollection 2015.

16.

In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose.

Grün BR, Berger U, Oberdorfer F, Hull WE, Ostertag H, Keppler D.

Adv Enzyme Regul. 1990;30:231-42.

PMID:
2403033
17.

Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs.

Winterdahl M, Keiding S, Sørensen M, Mortensen FV, Alstrup AK, Munk OL.

Eur J Nucl Med Mol Imaging. 2011 Feb;38(2):263-70. doi: 10.1007/s00259-010-1620-0. Epub 2010 Sep 30.

18.

Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma.

Horsager J, Bak-Fredslund K, Larsen LP, Villadsen GE, Bogsrud TV, Sørensen M.

EJNMMI Res. 2016 Dec;6(1):56. doi: 10.1186/s13550-016-0206-7. Epub 2016 Jun 24.

19.

Bringing physiology into PET of the liver.

Keiding S.

J Nucl Med. 2012 Mar;53(3):425-33. doi: 10.2967/jnumed.111.100214. Epub 2012 Feb 9. Review.

20.

Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.

Paul R, Aho K, Bergman J, Haaparanta M, Kulmala J, Reissell A, Solin O.

Int J Rad Appl Instrum B. 1989;16(5):449-53.

PMID:
2509402

Supplemental Content

Support Center